Tatsuya Niimi
Tsukuba, 3058585, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
DLiP-PPI library: An integrated chemical database of small-to-medium-sized molecules targeting protein-protein interactions.
Journal: Frontiers in chemistry
Published: November 05, 2022
Correction to NMR Biochemical Assay for Oxidosqualene Cyclase: Evaluation of Inhibitor Activities on Trypanosoma cruzi and Human Enzymes.
Journal: Journal of medicinal chemistry
Published: July 14, 2018
NMR Biochemical Assay for Oxidosqualene Cyclase: Evaluation of Inhibitor Activities on Trypanosoma cruzi and Human Enzymes.
Journal: Journal of medicinal chemistry
Published: May 18, 2018
Pharmacological and Structural Characterizations of Naquotinib, a Novel Third-Generation EGFR Tyrosine Kinase Inhibitor, in EGFR-Mutated Non-Small Cell Lung Cancer.
Journal: Molecular cancer therapeutics
Published: October 21, 2017
An NMR Biochemical Assay for Fragment-Based Drug Discovery: Evaluation of an Inhibitor Activity on Spermidine Synthase of Trypanosoma cruzi.
Journal: Journal of medicinal chemistry
Published: February 17, 2016
In silico, in vitro, X-ray crystallography, and integrated strategies for discovering spermidine synthase inhibitors for Chagas disease.
Journal: Scientific reports
Published: February 05, 2016
Structural insights into the novel inhibition mechanism of Trypanosoma cruzi spermidine synthase.
Journal: Acta crystallographica. Section D, Biological crystallography
Published: March 23, 2015
Structures of complexes of type 5 17β-hydroxysteroid dehydrogenase with structurally diverse inhibitors: insights into the conformational changes upon inhibitor binding.
Journal: Acta crystallographica. Section D, Biological crystallography
Published: September 10, 2014
In vitro and in vivo characterisation of ASP9521: a novel, selective, orally bioavailable inhibitor of 17β-hydroxysteroid dehydrogenase type 5 (17βHSD5; AKR1C3).
Journal: Investigational new drugs
Published: May 13, 2014
Distinct properties of telmisartan on agonistic activities for peroxisome proliferator-activated receptor γ among clinically used angiotensin II receptor blockers: drug-target interaction analyses.
Journal: The Journal of pharmacology and experimental therapeutics
Published: January 16, 2014
4-Hydroxypyridazin-3(2H)-one derivatives as novel D-amino acid oxidase inhibitors.
Journal: Journal of medicinal chemistry
Published: April 10, 2013
Structural basis for telmisartan-mediated partial activation of PPAR gamma.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: February 24, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026